Zhengye Biotechnology Stock Is Trading Lower On Monday: What's Going On?

Benzinga·06/23/2025 20:11:45

Listen to the news

Zhengye Biotechnology Holding (NASDAQ:ZYBT) shares are trading lower after the company announced it received a Nasdaq noncompliance notice.

What To Know: Zhengye said it received a letter from the Nasdaq Stock Market on May 20, stating that it is not in compliance with listing rules due to its failure to timely file its annual report for the fiscal year ended Dec. 31, 2024.

The company has 60 calendar days from the date of the notice to submit a plan to regain compliance. If Nasdaq accepts the plan, Zhengye may be granted an extension of up to 180 days, or until Nov. 11 to file the report.

The company said the notice has no immediate effect on the listing of its ordinary shares on the Nasdaq Capital Market.

ZYBT Price Action: At publication on Monday, Zhengye shares are trading 20.16% lower at $7.43, according to data from Benzinga Pro.

Image: This illustration was generated using artificial intelligence via Midjourney.

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English